(Q33919332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Predictive and prognostic factors in small cell lung cancer: current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

P G Harper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

173-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Prognosis at presentation of small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Prognostic factors and prognostic staging system for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Cancer in the elderly: gathering the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Small-cell lung cancer in elderly patients: the case for chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Treatment of small cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Influence of age on the treatment of limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Detection of large cell component in small cell lung carcinoma by combined cytologic and histologic examinations and its clinical implication

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health organization. A study of 375 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Flow cytometric analysis of tumor DNA profile related to response to treatment and survival in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Clinical significance of DNA measurements in small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

The impact of abdominal computerized tomography on the pretreatment staging and prognosis of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

Management of patients with small cell carcinoma and the syndrome of ectopic corticotropin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900105-7

7 January 2021

10.1016/S0169-5002(00)00105-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812187%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference